Novel Antimicrobials and AMR Diagnostics 2019


New European CARB-X Accelerator in Switzerland successfully applied to join CARB-X Global Accelerator Network

With companies such as Basilea, BioVersys, Idorsia, Polyphor and Roche, the Basel region is a leading science hotspot and major centre for antibiotics research. now successfully joined the CARB-X Global Accelerator Network. This milestone is expected to strengthen the network of AMR-related companies and institutions further as well as to support potential candidates in applying for CARB-X funding. Malcom Page, an independent expert in the field of AMR and former Head of Biology at Basilea will join the CARB-X accelerator and provide advice.

CARB-X funded companies benefit from advise from AMR specialists. This can include support with drug development strategies, chemistry reviews, business strategy counselling, intellectual property, investor relations or partnering. Kevin Outterson from CARB-X will join the AMR conference and contribute to the discussion in the policy session on how to leverage public and private support to finance AMR innovation.

Read the entire article